CliffBio
small molecule

DIVIGEL

ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyVertical →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIVIGEL
Active ingredientESTRADIOL
Strength0.1% (0.75GM/PACKET)
Dosage formGEL
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalAugust 2018
Marketing statusRX

More from Vertical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DIVIGEL patent cliff — loss of exclusivity — | CliffBio